cladosporol

a phtyogenic antineoplastic agent; structure in ifirst source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Colorectal Neoplasms (Colorectal Cancer) 11/01/2021 - "Finally, we found that proliferation and migration of HT-29 colorectal cancer cells were inhibited by conditioned medium from cladosporol-treated 3T3-L1 cells compared with the preadipocyte conditioned medium. "
2.	Stomach Neoplasms (Stomach Cancer) 12/01/2009 - "In vivo, cladosporol also showed antitumor activity in nude mice bearing MGC-803 gastric cancer xenografts. "
3.	Neoplasms (Cancer) 12/01/2009 - "The results showed that cladosporol selectively killed cancer cells and had a significant inhibitory effect on the human gastric carcinoma cell line MGC-803 in a concentration- and time-dependent manner. " 12/01/2009 - "The growth-inhibitory effects of cladosporol in vitro against six human cancer cell lines were examined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. "
4.	Carcinoma (Carcinomatosis) 12/01/2009 - "These findings suggest that cladosporol has potentially useful growth inhibitory effects on human gastric carcinoma cell lines." 12/01/2009 - "The results showed that cladosporol selectively killed cancer cells and had a significant inhibitory effect on the human gastric carcinoma cell line MGC-803 in a concentration- and time-dependent manner. " 12/01/2009 - "Inhibition of human gastric carcinoma cell growth in vitro and in vivo by cladosporol isolated from the paclitaxel-producing strain Alternaria alternata var. monosporus."